Crystalline form of methyl ((1s)-1-(((2s)-2-(5-(4'-(2-((2s)-1-((2s)-2-( (methoxycarbonyl)amino)-3-methylbuta noyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)-4biphenylyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)car bonyl)-2-methylpropyl)carbamate dihydrochloride salt

Details for Australian Patent Application No. 2008284100 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Yang, Fukang; Kim, Soojin; Gao, Qi

Agent A J Park

Pub. Number AU-A-2008284100

PCT Pub. Number WO2009/020828

Priority 60/954,592 08.08.07 US

Filing date 31 July 2008

Wipo publication date 12 February 2009

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4178 (2006.01)

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

4 March 2010 PCT application entered the National Phase

  PCT publication WO2009/020828 Priority application(s): WO2009/020828

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008284101-Delayed breaker

2008284097-Process for synthesizing compounds useful for treating hepatitis C